Prostate cancer (PC) is an extremely heterogeneous tumor and clinical decisions continue to depend upon serum prostate-specific antigen (PSA) levels, tumor stage, risk classes, and Gleason score [1,2]. Here, KLK3 is linked to prostate cancer.